Physician profile
Daphne Lynn Bryan
NPI 1538245295
$2,467.18
in general payments reported to CMS, 2019-2025
18 companies · $195 in 2025
The $195 reported for 2025 was more than what a typical Obesity Medicine (Family Medicine) provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $510 · 2020: $11.47 · 2021: $251 · 2022: $297 · 2023: $146 · 2024: $1,057 · 2025: $195.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $700 · Food and Beverage: $698.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $700.00 |
| Food and Beverage | $697.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,001.58 | 2019-2025 | Wegovy |
| Eli Lilly and Company | $700.00 | 2024 | |
| Lilly USA, LLC | $264.63 | 2019-2025 | Zepbound |
| Innocoll Pharmaceuticals Limited | $108.48 | 2021 | |
| Abbvie INC. | $81.67 | 2021-2023 | Ubrelvy |
| Currax Pharmaceuticals LLC | $44.91 | 2019-2022 | |
| Nalpropion Pharmaceuticals LLC | $41.01 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $39.02 | 2019 | |
| Dexcom, INC. | $36.86 | 2022 | |
| Pfizer INC. | $30.62 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $18.05 | 2021 | |
| Medtronic, INC. | $17.54 | 2024 | Progrip |
| Abbott Laboratories | $17.39 | 2023 | Freestyle Libre 3 |
| Trevena, INC. | $14.79 | 2022 | |
| Shire North American Group INC | $14.71 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dynavax Technologies Corporation | $12.31 | 2022 | |
| Davol INC. | $11.91 | 2021 | |
| Sanofi-Aventis U.S. LLC | $11.70 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daphne Bryan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.